Immunome
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2008-01-01
- Employees
- 55
- Market Cap
- $899M
- Website
- http://www.immunome.com
- Introduction
Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas. The company was founded by Scott K. Dessain and Gregory P. Licholai on March 2, 2006 and is headquartered in Bothell, WA.
A Cardiac Liability Study of Varegacestat in Healthy Participants
- Conditions
- Healthy Volunteer
- Interventions
- First Posted Date
- 2025-03-03
- Last Posted Date
- 2025-04-18
- Lead Sponsor
- Immunome, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT06855264
- Locations
- 🇺🇸
Celerion, Tempe, Arizona, United States
A Phase 1 Mass Balance Study of Varegacestat
- First Posted Date
- 2025-02-25
- Last Posted Date
- 2025-04-06
- Lead Sponsor
- Immunome, Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT06845852
- Locations
- 🇺🇸
Frontage Laboratories, Inc., Secaucus, New Jersey, United States
A Varegacestat Hepatic Impairment Study
- First Posted Date
- 2025-02-24
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Immunome, Inc.
- Target Recruit Count
- 44
- Registration Number
- NCT06841315
- Locations
- 🇺🇸
Orlando Clinical Research Center, Orlando, Florida, United States
🇺🇸The Texas Liver Institute, San Antonio, Texas, United States
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
- Conditions
- Solid MalignanciesHematologic Malignancies
- Interventions
- First Posted Date
- 2025-02-12
- Last Posted Date
- 2025-05-02
- Lead Sponsor
- Immunome, Inc.
- Target Recruit Count
- 117
- Registration Number
- NCT06823167
- Locations
- 🇺🇸
START Midwest, Grand Rapids, Michigan, United States
🇺🇸NEXT Oncology, Irving, Texas, United States
A Phase 1 Study to Examine the Effects of Itraconazole After Single Dose Administration of Varegacestat (AL102) to Healthy Participants
- Conditions
- Healthy Volunteer
- Interventions
- First Posted Date
- 2024-11-07
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- Immunome, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT06677996
- Locations
- 🇺🇸
Celerion, Tempe, Arizona, United States
IMM-BCP-01 in Mild to Moderate COVID-19
- First Posted Date
- 2022-06-23
- Last Posted Date
- 2022-08-12
- Lead Sponsor
- Immunome, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT05429021
- Locations
- 🇺🇸
Ark Clinical Research, Long Beach, California, United States
🇺🇸Panax Clinical Research, Miami Lakes, Florida, United States
🇺🇸Icahn School of Medicine at Mt. Sinai, New York, New York, United States